Invex Therapeutics Ltd has released a press release.
Invex receives R&D Tax Rebate
Filed with ASX ·
6ix hasn’t read this filing yet.
Invex Therapeutics Ltd. on 6ix
Story so far
Earlier from Invex Therapeutics
- ATO Class Ruling Return of Capital
- Appendix 4D and Half year report
- Invex and Peptron Mutually Terminate Manufacturing Agreement
- Invex Granted European Patent for Exenatide in Hydrocephalus
- Proposed Capital Return to Shareholders of $14.0 Million
Later from Invex Therapeutics
- Quarterly Activities Report and Appendix 4C
- Improved Neuronal Cell Survival in 3D Model of Alzheimer's
- Invex Receives $0.22m R&D Tax Rebate from UK Government
- Appendix 4E and Annual Report to shareholders
- Trading Halt
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics